178 related articles for article (PubMed ID: 10758060)
1. Molecular basis of cardiovascular drug metabolism: implications for predicting clinically important drug interactions.
Abernethy DR; Flockhart DA
Circulation; 2000 Apr; 101(14):1749-53. PubMed ID: 10758060
[No Abstract] [Full Text] [Related]
2. Polarized cell cultures for integrated studies of drug metabolism and transport.
Brimer-Cline C; Schuetz EG
Methods Enzymol; 2002; 357():321-9. PubMed ID: 12424922
[No Abstract] [Full Text] [Related]
3. Drug interactions: Proteins, pumps, and P-450s.
Shapiro LE; Shear NH
J Am Acad Dermatol; 2002 Oct; 47(4):467-84; quiz 485-8. PubMed ID: 12271287
[TBL] [Abstract][Full Text] [Related]
4. Considerations in the design and development of transport inhibitors as adjuncts to drug therapy.
Dantzig AH; de Alwis DP; Burgess M
Adv Drug Deliv Rev; 2003 Jan; 55(1):133-50. PubMed ID: 12535578
[TBL] [Abstract][Full Text] [Related]
5. Drug-herb interactions: eliminating toxicity with hard drug design.
Yang XX; Hu ZP; Duan W; Zhu YZ; Zhou SF
Curr Pharm Des; 2006; 12(35):4649-64. PubMed ID: 17168768
[TBL] [Abstract][Full Text] [Related]
6. Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs.
Patel J; Mitra AK
Pharmacogenomics; 2001 Nov; 2(4):401-15. PubMed ID: 11722289
[TBL] [Abstract][Full Text] [Related]
7. [Drug interactions: new mechanisms and clinical relevance].
Paneitz A; Meissner K; Kroemer HK
Internist (Berl); 2000 Apr; 41(4):338-43. PubMed ID: 10798181
[No Abstract] [Full Text] [Related]
8. Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.
Hochman JH; Yamazaki M; Ohe T; Lin JH
Curr Drug Metab; 2002 Jun; 3(3):257-73. PubMed ID: 12083320
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein-dependent trafficking of nanoparticle-drug conjugates.
Dreaden EC; Raji IO; Austin LA; Fathi S; Mwakwari SC; Humphries WH; Kang B; Oyelere AK; El-Sayed MA
Small; 2014 May; 10(9):1719-23. PubMed ID: 24616407
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics and metabolic drug interactions.
Leucuta SE; Vlase L
Curr Clin Pharmacol; 2006 Jan; 1(1):5-20. PubMed ID: 18666374
[TBL] [Abstract][Full Text] [Related]
11. [Clinically relevant adverse drug interactions].
Martin-Facklam M; Haefeli WE
Ther Umsch; 2000 Sep; 57(9):579-83. PubMed ID: 11036439
[TBL] [Abstract][Full Text] [Related]
12. [Drug transporter studies in drug discovery and development].
Mizuno N; Niwa T
Nihon Yakurigaku Zasshi; 2005 Apr; 125(4):200-6. PubMed ID: 15930796
[No Abstract] [Full Text] [Related]
13. Potential of pharmacokinetic profiling for detecting herbal interactions with drugs.
Butterweck V; Derendorf H
Clin Pharmacokinet; 2008; 47(6):383-97. PubMed ID: 18479173
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics--drug disposition, drug targets, and side effects.
Evans WE; McLeod HL
N Engl J Med; 2003 Feb; 348(6):538-49. PubMed ID: 12571262
[No Abstract] [Full Text] [Related]
15. Mechanistic study of the cellular interplay of transport and metabolism using the synthetic modeling method.
Liu Y; Hunt CA
Pharm Res; 2006 Mar; 23(3):493-505. PubMed ID: 16435171
[TBL] [Abstract][Full Text] [Related]
16. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Pedersen JM; Matsson P; Bergström CA; Norinder U; Hoogstraate J; Artursson P
J Med Chem; 2008 Jun; 51(11):3275-87. PubMed ID: 18457386
[TBL] [Abstract][Full Text] [Related]
17. A regulatory viewpoint on transporter-based drug interactions.
Zhang L; Zhang YD; Strong JM; Reynolds KS; Huang SM
Xenobiotica; 2008 Jul; 38(7-8):709-24. PubMed ID: 18668428
[TBL] [Abstract][Full Text] [Related]
18. Natural products and adverse drug interactions.
Bailey DG; Dresser GK
CMAJ; 2004 May; 170(10):1531-2. PubMed ID: 15136542
[No Abstract] [Full Text] [Related]
19. "Inactive" excipients such as Cremophor can affect in vivo drug disposition.
Wandel C; Kim RB; Stein CM
Clin Pharmacol Ther; 2003 May; 73(5):394-6. PubMed ID: 12732839
[No Abstract] [Full Text] [Related]
20. Relationship between drugs and functional activity of various mammalian P-glycoproteins (ABCB1).
Kim IW; Booth-Genthe C; Ambudkar SV
Mini Rev Med Chem; 2008 Mar; 8(3):193-200. PubMed ID: 18336339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
